Abstract
The gating of large-conductance Ca2+-activated K+ (BKCa) channel is primarily controlled by intracellular Ca2+ and/or membrane depolarization. These channels play a role in the coupling of excitation-contraction and stimulussecretion. A variety of structurally distinct compounds may influence the activity of these channels. Squamocin, an Annonaceous acetogenin, could interact with the BKCa channel to increase the amplitude of Ca2+-activated K+ current in coronary smooth muscle cells. Its stimulatory effect is related to intracellular Ca2+ concentrations. In inside-out patches, application of ceramide to the bath suppressed the activity of BKCa channels recorded from pituitary GH3 cells and from retinal pigment epithelial cells. ICI-182,780, an estrogen receptor antagonist, was found to modulate BKCa-channel activity in cultured endothelial cells and smooth muscle cells in a mechanism unlinked to the inhibition of estrogen receptors. Caffeic acid phenethyl ester (CAPE) and its analogy, cinnamyl-3,4-dihydroxy-α-cyanocinnamate, could directly increase the activity of BKCa channels in GH3 cells. CAPE also reduced the frequency and amplitude of intracellular Ca2+ oscillations in these cells. The CAPE-stimulated activity in BKCa channels is thought to be unassociated with its inhibition of NF-kB activation. Cilostazol, an inhibitor of cyclic nucleotide phosphodiesterase, could stimulate BKCa channel-activity and reduce the firing of action currents simultaneously in GH3 cells. Therefore, the regulation by these compounds of BKCa channels may in part be responsible for their regulatory actions on cell functions.
Keywords: Large-conductance Ca2+-activated K+ (BKCa) channel, Ca2+-activated K+ current, intracellular Ca2+, BKCa channel opener, BKCa channel inhibitor
Current Topics in Medicinal Chemistry
Title: Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel
Volume: 6 Issue: 10
Author(s): Sheng-Nan Wu, Adonis Z Wu and Ming-Wei Lin
Affiliation:
Keywords: Large-conductance Ca2+-activated K+ (BKCa) channel, Ca2+-activated K+ current, intracellular Ca2+, BKCa channel opener, BKCa channel inhibitor
Abstract: The gating of large-conductance Ca2+-activated K+ (BKCa) channel is primarily controlled by intracellular Ca2+ and/or membrane depolarization. These channels play a role in the coupling of excitation-contraction and stimulussecretion. A variety of structurally distinct compounds may influence the activity of these channels. Squamocin, an Annonaceous acetogenin, could interact with the BKCa channel to increase the amplitude of Ca2+-activated K+ current in coronary smooth muscle cells. Its stimulatory effect is related to intracellular Ca2+ concentrations. In inside-out patches, application of ceramide to the bath suppressed the activity of BKCa channels recorded from pituitary GH3 cells and from retinal pigment epithelial cells. ICI-182,780, an estrogen receptor antagonist, was found to modulate BKCa-channel activity in cultured endothelial cells and smooth muscle cells in a mechanism unlinked to the inhibition of estrogen receptors. Caffeic acid phenethyl ester (CAPE) and its analogy, cinnamyl-3,4-dihydroxy-α-cyanocinnamate, could directly increase the activity of BKCa channels in GH3 cells. CAPE also reduced the frequency and amplitude of intracellular Ca2+ oscillations in these cells. The CAPE-stimulated activity in BKCa channels is thought to be unassociated with its inhibition of NF-kB activation. Cilostazol, an inhibitor of cyclic nucleotide phosphodiesterase, could stimulate BKCa channel-activity and reduce the firing of action currents simultaneously in GH3 cells. Therefore, the regulation by these compounds of BKCa channels may in part be responsible for their regulatory actions on cell functions.
Export Options
About this article
Cite this article as:
Wu Sheng-Nan, Wu Z Adonis and Lin Ming-Wei, Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel, Current Topics in Medicinal Chemistry 2006; 6 (10) . https://dx.doi.org/10.2174/156802606777323764
DOI https://dx.doi.org/10.2174/156802606777323764 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical Applications
Current Stem Cell Research & Therapy Erlotinib in Glioblastoma - Lost in Translation?
Anti-Cancer Agents in Medicinal Chemistry Cell-Based Assay System to Estimate the Effect of 125I Seeds on Cancer Cells: Effect of Osteopontin
Recent Patents on Anti-Cancer Drug Discovery The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?
Recent Patents on Anti-Cancer Drug Discovery miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry Hybrid Compounds Containing Carvacrol Scaffold: <i>In Vitro</i> Antibacterial and Cytotoxicity Evaluation
Recent Advances in Anti-Infective Drug Discovery Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Targeted Liposomal Drug Delivery in Cancer
Current Pharmaceutical Design The Potential Therapeutic Value of Renin-Angiotensin System Inhibitors in the Treatment of Colorectal Cancer
Current Pharmaceutical Design Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Considering Autotaxin Inhibitors in Terms of 2D-QSAR and 3D-Mapping- Review and Evaluation
Current Medicinal Chemistry Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Medicinal Chemistry Subject Index To Volune 2
Current Cancer Therapy Reviews Thalidomide: An Overview of its Pharmacological Mechanisms of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Glutathione Transferases: Emerging Multidisciplinary Tools in Red and Green Biotechnology
Recent Patents on Biotechnology Nano-constructed Carriers Loaded With Antioxidant: Boon For Cardiovascular System
Current Pharmaceutical Design DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects
Current Pharmaceutical Design Smac-Derived Aza-Peptide As an Aminopeptidase-Resistant XIAP BIR3 Antagonist
Protein & Peptide Letters